---
title: "GUANGJI PHARMA released its performance for the first half of the year, with a net loss attributable to the parent company of 75.5151 million yuan"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/254955209.md"
description: "According to the Zhitong Finance APP, GUANGJI PHARMA released its semi-annual report for 2025. During the reporting period, the company achieved operating revenue of 284 million yuan, a year-on-year decrease of 4.08%. The net loss attributable to shareholders of the listed company was 75.5151 million yuan, and the net loss attributable to shareholders of the listed company after deducting non-recurring gains and losses was 78.4109 million yuan, with a basic loss per share of 0.2158 yuan"
datetime: "2025-08-28T08:44:12.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/254955209.md)
  - [en](https://longbridge.com/en/news/254955209.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/254955209.md)
---

# GUANGJI PHARMA released its performance for the first half of the year, with a net loss attributable to the parent company of 75.5151 million yuan

According to the Zhitong Finance APP, GUANGJI PHARMA (000952.SZ) released its semi-annual report for 2025. During the reporting period, the company achieved operating revenue of 284 million yuan, a year-on-year decrease of 4.08%. The net loss attributable to shareholders of the listed company was 75.5151 million yuan, and the net loss attributable to shareholders of the listed company after deducting non-recurring gains and losses was 78.4109 million yuan, with a basic loss per share of 0.2158 yuan

### Related Stocks

- [000952.CN](https://longbridge.com/en/quote/000952.CN.md)

## Related News & Research

- [BREAKINGVIEWS-China's outbound M&A spree has staying power](https://longbridge.com/en/news/286850954.md)
- [Flow Pharma U.S. Patent Application Allowed for Issuance Covering Broad-Spectrum Ebola Therapy](https://longbridge.com/en/news/287076761.md)
- [15:37 ETMuse Communications Celebrates 10 Years of Award-Winning Legal Marketing and Public Relations](https://longbridge.com/en/news/286811115.md)
- [Nuclear reactor developer Deep Fission eyes $1.66 billion valuation in US IPO](https://longbridge.com/en/news/287062992.md)
- [PRECIOUS-Treasury yields, dollar weigh on gold amid inflation concerns](https://longbridge.com/en/news/286929968.md)